Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells

Effective adoptive T cell therapy (ACT) comprises the killing of cancer cells through the therapeutic use of transferred T cells. One of the main ACT approaches is chimeric antigen receptor (CAR) T cell therapy. CAR T cells mediate MHC-unrestricted tumor cell killing by enabling T cells to bind targ...

Descripción completa

Detalles Bibliográficos
Autores principales: Benmebarek, Mohamed-Reda, Karches, Clara Helke, Cadilha, Bruno Loureiro, Lesch, Stefanie, Endres, Stefan, Kobold, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470706/
https://www.ncbi.nlm.nih.gov/pubmed/30875739
http://dx.doi.org/10.3390/ijms20061283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470706/
https://www.ncbi.nlm.nih.gov/pubmed/30875739
http://dx.doi.org/10.3390/ijms20061283

Ejemplares similares